A Next Generation TCR & Epitope Discovery Platform for the Development of Engineered TCR Therapies for Solid Tumours

Time: 11:00 am
day: Day 1 - Track A - Morning


  • HuTCR, an innovative platform based on complex genetic engineering, leverages natural immune processes to generate TCRs with optimal affinity and high specificity
  • Parallel epitope discovery and TCR identification to enhance throughput and reduce discovery lead time
  • TK-8001, a CD8 TCR-T specific for a MAGE-A1 epitope presented on HLA-A*02-01